LanzaTech Global, Inc. (LNZA) Stock

LanzaTech Global, Inc. (LNZA) is a Materials stock trading at $5.60 (as of 2026-07-24), with a market capitalization of $56.50M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

LanzaTech Global, Inc. operates as a nature-based carbon refining company in the United States and internationally. The company transforms waste carbon into the chemical building blocks for consumer goods, such as sustainable fuels, fabrics, and packaging. LanzaTech Global, Inc. was founded in 2005 and is headquartered in Skokie, Illinois.

Understand LanzaTech Global, Inc.: how it makes money

LanzaTech Global, Inc. turns waste carbon into chemical building blocks used in products like sustainable fuels, fabrics, and packaging, and it monetizes this work through biorefining and related carbon capture and utilization revenue, plus other streams such as R&D and engineering services, and potentially licensing and contract research.

The profit model is built on whether LanzaTech can scale and sell (or license) its waste-to-chemical outputs, because its revenue streams are tied to biorefining and carbon capture and utilization execution, with additional support from services and licensing.

Revenue by segment (latest quarter)
Bio$0.0B
CarbonSmart$0.0B
Licensing$0.0B
ContractRes$0.0B
JDA+CR$0.0B

Business quality (Weak): The latest quarter shows revenue of 0.0B and a very negative operating margin (-81.6%), and the provided segment-style revenue categories all round to 0.0B, so there is limited visibility into a repeatable, scalable commercial profit driver yet.

Bull case

  • Product positioning is aimed at consumer goods value chains, using waste carbon to produce chemical building blocks for sustainable fuels, fabrics, and packaging: If projects scale, the company has a clear pathway from waste-carbon processing into marketable outputs.
  • The operating footprint is organized around specific projects and capacities (including Project Drake Capacity and Project Secure Sustainable Ethylene Output): Project progress can provide a tangible view of commercialization momentum beyond only financial statements.

Bear case

  • Operating profitability is deeply negative in the latest quarter, with an operating margin of -81.6%: This suggests the current cost structure and/or early-stage commercialization have not yet translated into operating leverage.
  • Revenue is reported as 0.0B for the latest quarter (2026-03-31): With revenue rounding to zero in the provided data, it is harder to confirm a steady, recurring commercial revenue base.
Valuation — source: SEC EDGAR (first-party)
Price$5.60
Market Cap$56.50M
Price / Book1.18
Price / Sales1.42
FCF Yield-238.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$55.84M
Net Margin-87.7%
Revenue Growth (YoY)12.6%
EPS Growth (YoY)3081.4%
FCF Growth (YoY)-29.9%
Financial Health — source: SEC EDGAR
Altman Z-Score-15.81 (distress)
Valuation vs Sector & Industry
Sector P/E (Materials)27.1
Industry P/E (Chemicals)31.7
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderNOVO HOLDINGS A/S ($2.53M)
Institutional Holders Tracked10
Company
SectorMaterials
IndustryChemicals
CEOJennifer Holmgren
Employees383
CountryUS
IPO Date2021-09-24

Related Companies (Business model: Closed-End Fund; 8 closest by market cap; US-domiciled)

  • Larimar Therapeutics, Inc. (LRMR)
  • Lightbridge Corporation (LTBR)
  • Comstock Inc. (LODE)
  • LeonaBio, Inc. (LONA)
  • Advanced Flower Capital Inc. (AFCG)
  • Laird Superfood, Inc. (LSF)
  • Lipocine Inc. (LPCN)
  • Lisata Therapeutics, Inc. (LSTA)
LNZA earnings history · LNZA institutional & insider holders · LNZA KPIs & operating metrics · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-07-24.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.